Jun 15, 2026 07:07AM
Jun 9, 2026 06:51AM
Jun 3, 2026 04:30AM
May 7, 2026 07:40AM
May 6, 2026 04:01PM
Apr 15, 2026 04:36PM
Apr 8, 2026 08:02AM Ascendis shows combination therapy benefits in achondroplasia trial
Apr 6, 2026 04:01PM
Apr 1, 2026 07:03AM
Mar 18, 2026 09:21AM
Mar 17, 2026 08:32AM
Mar 5, 2026 04:18PM
Mar 4, 2026 03:22PM
Mar 2, 2026 03:49PM Ascendis Pharma (ASND) PT Raised to $275 at RBC Capital
Mar 2, 2026 03:21PM
Mar 2, 2026 12:56PM
Mar 2, 2026 10:59AM
Mar 2, 2026 10:38AM
Mar 2, 2026 10:03AM
Mar 2, 2026 09:19AM
Mar 2, 2026 04:55AM Ascendis Pharma (ASND) PT Raised to $255 at Goldman Sachs
Feb 23, 2026 08:58AM
Feb 12, 2026 01:54PM
Feb 12, 2026 10:03AM
Feb 12, 2026 07:41AM
Feb 11, 2026 04:01PM
Jan 22, 2026 11:56AM
Jan 20, 2026 05:30AM Ascendis Pharma (ASND) PT Raised to $250 at RBC Capital
Jan 12, 2026 08:26AM
Jan 12, 2026 08:18AM
Jan 9, 2026 07:10AM
Jan 8, 2026 04:04PM
Jan 8, 2026 08:49AM
Jan 7, 2026 09:13AM
Dec 12, 2025 03:22PM Ascendis Pharma (ASND) Gains Appear to be Tied to Unconfirmed M&A Chatter
Nov 26, 2025 07:00AM
Nov 26, 2025 06:48AM
Nov 24, 2025 08:53AM
Nov 17, 2025 04:10PM
Nov 17, 2025 04:01PM
Nov 16, 2025 03:00PM
Nov 13, 2025 06:55AM Ascendis Pharma (ASND) Looks at Decreased FY2025-26 Revenues - Cantor Fitzgerald
Nov 13, 2025 04:04AM
Nov 12, 2025 04:05PM
Nov 7, 2025 08:31AM
Oct 16, 2025 04:06PM
Oct 13, 2025 07:21AM
Oct 12, 2025 03:00PM
Oct 8, 2025 04:01PM Ascendis submits European approval application for achondroplasia drug
Sep 24, 2025 06:00AM

404,873 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All